Clinical Trial Update: A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating AOH1996 in relapsed or refractory acute myeloid leukemia is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AOH1996

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | Status: SUSPENDED